SWOG clinical trial number
CTSU/EA8141

A Prospective Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery for Patients with High Grade Upper Tract Urothelial Carcinoma

Closed
Phase
Abbreviated Title
Pro Phase II Neo Sys Chem Followed by Extir Surg for HG UTCC
Activated
04/10/2015
Participants
CTSU

Research committees

Genitourinary Cancer

Treatment

Cisplatin Carboplatin Doxorubicin Gemcitabine hydrochloride Methotrexate Vinblastine Pegfilgrastim

Publication Information Expand/Collapse

2024

Addition or Substitution of Acalabrutinib in Intensive Frontline Chemoimmunotherapy for Younger Patients with Mantle Cell Lymphoma: Clinical Outcomes of the 3-Arm Randomized Phase II Intergroup Trial ECOG-ACRIN EA4181

N Wagner-Johnston;O Jegede;S Spurgeon;K Maddocks;D Yang;J Romanoff;J Paludo;P Caimi;N Bartlett;P Reagan;Y Sawalha;M Hoffmann;B Hu;A Aziz;H Marques;L Kostakoglu Shields;J Leonard;JW Friedberg;B Kahl ASH Annual Meeting (December 7-10, 2024, in San Diego, CA), oral

2020

Results of a Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery for Patients with High Grade Upper Tract Urothelial Carcinoma

V Margulis;M Puliigandla;E Trabulsi;E Plimack;E Kessler;S Matin;G Godoy;A Alva;N Hahn;M Carducci;J Hoffman-Censits Journal of Urology Apr;203(4):690-698; Nov 8:101097JU0000000000000644.[Epub ahead of print]

PMid: PMID31702432

2018

Phase II trial of neoadjuvant chemotherapy followed by extirpative surgery for patients with high grade upper tract urothelial carcinoma (HG UTUC): results from ECOG-ACRIN 8141

J Hoffman-Censits;M Puligandla;E Trabulski;E Plimack;E Kessler;S Matin;G Godoy;A Alva;N Hahn;M Carducci;V Margulis Journal of Urology Vol. 199, No. 4S, Supplement, LBA26, p. e1166; American Urological Association Annual Meeting 2018

Other Clinical Trials

SWOG Clinical Trial Number
S2427

Single Arm Phase II Study of Bladder Preservation with Immunoradiotherapy after a Clinically Meaningful Response to Neoadjuvant Therapy in Patients with Muscle Invasive Bladder Cancer (BRIGHT)
Research Committee(s)
Genitourinary Cancer
Activated
09/04/2025
Accrual
1%
Open
Phase
SWOG Clinical Trial Number
CCTG-PR26

A Randomized Phase III Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response (TRIPLE-SWITCH)
Research Committee(s)
Genitourinary Cancer
Activated
01/30/2025
Open
Phase
SWOG Clinical Trial Number
S2312

A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with metastatic castrate-resistant prostate cancer (mCRPC), Stratified by Aggressive Variant Signature
Research Committee(s)
Genitourinary Cancer
Activated
09/03/2024
Accrual
7%
Open
Phase